AVD:NYE-American Vanguard Corporation

COMMON STOCK | Agricultural Inputs | NYE

Last Closing Price

USD 13.34

Change

-0.09 (-0.67)%

Market Cap

USD 0.41B

Volume

0.11M

Average Target Price

USD 19.00 (+0.00%)
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. It also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as PCNB, chlorothalonil, and propiconazole under the FFII and FFIII names. The company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. American Vanguard Corporation was founded in 1969 and is headquartered in Newport Beach, California.

Market Stats

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-22 )

Largest Industry Peers for Agricultural Inputs

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NTR Nutrien Ltd

-0.33 (-0.67%)

USD 28.03B 9.66 9.48
CTVA Corteva, Inc

+0.48 (+1.88%)

USD 19.50B N/A 62.84
FMC FMC Corporation

-1.38 (-1.65%)

USD 10.83B 22.48 10.88
CF CF Industries Holdings, Inc

-0.05 (-0.11%)

USD 10.43B 24.13 9.74
MOS The Mosaic Company

+0.21 (+1.08%)

USD 7.54B 29.58 6.14
ICL Israel Chemicals Ltd

-0.10 (-2.13%)

USD 6.00B 11.92 19.25
SMG The Scotts Miracle-Gro Company

-0.55 (-0.54%)

USD 5.56B 15.15 14.32
IPI Intrepid Potash, Inc

-0.04 (-1.28%)

USD 0.41B 18.35 8.09
UAN CVR Partners, LP

+0.02 (+0.57%)

USD 0.40B 23.50 7.39
BIOX Bioceres Crop Solutions Corp

-0.16 (-2.44%)

USD 0.23B N/A 23.59

ETFs Containing AVD

Symbol Name Weight Mer Price(Change) Market Cap
PAGG 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Agricultural Inputs)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.18% 40% F 13% F
Dividend Return 0.39% 13% F 5% F
Total Return -11.78% 40% F 13% F
Trailing 12 Months  
Capital Gain -17.76% 40% F 18% F
Dividend Return 0.49% 25% F 5% F
Total Return -17.26% 40% F 16% F
Trailing 5 Years  
Capital Gain 36.68% 78% C+ 72% C-
Dividend Return 2.77% 13% F 10% F
Total Return 39.45% 78% C+ 64% D
Average Annual (5 Year Horizon)  
Capital Gain 10.25% 80% B- 81% B-
Dividend Return 0.28% 22% F 7% F
Total Return 10.53% 70% C- 76% C
Risk Return Profile  
Volatility (Standard Deviation) 25.49% 70% C- 25% F
Risk Adjusted Return 41.32% 80% B- 54% F
Market Capitalization 0.41B 33% F 42% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Agricultural Inputs)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.99 50% F 43% F
Price/Book Ratio 1.22 50% F 60% D-
Price / Cash Flow Ratio 35.99 8% F 7% F
EV/EBITDA 9.73 58% F 50% F
Management Effectiveness  
Return on Equity 6.39% 67% D+ 44% F
Return on Invested Capital 6.74% 58% F 52% F
Return on Assets 3.64% 75% C 63% D
Debt to Equity Ratio 29.36% 75% C 78% C+
Technical Ratios  
Short Ratio 7.10 25% F 15% F
Short Percent 3.10% 42% F 70% C-
Beta 1.25 40% F 27% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.